News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
FOSUN PHARMA Clinches Strategic Partnership with Fakeeh Care Group to Extend Product Reach to Mideast
FOSUN PHARMA (02196.HK) announced a strategic partnership with Saudi Arabia’s Fakeeh Care Group, an integrated healthcare group, to jointly promote biologics, CAR-T cell ther...
Reset
Send
The window will close in 5 seconds
FOSUN PHARMA Clinches Strategic Partnership with Fakeeh Care Group to Extend Product Reach to Mideast
Close
Recommend
1
Positive
2
Negative
3
 
SHORT SELL
 
STOCK INFO

FOSUN PHARMA (02196.HK)  +0.020 (+0.143%)    Short selling $2.78M; Ratio 5.995%   announced a strategic partnership with Saudi Arabia’s Fakeeh Care Group, an integrated healthcare group, to jointly promote biologics, CAR-T cell therapies, and other cutting-edge treatments in Saudi Arabia, accelerating local medical innovation.

Guo Guangchang, Chairman of Fosun International, expressed optimism about establishing a long-term stable strategic relationship with Fakeeh Care Group to deliver integrated global healthcare services. Leveraging its global operational capabilities, Fosun aims to achieve sustainable value growth with Middle Eastern partners.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-08 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.